Development of Hepatocellular Carcinomas in Patients with Absence of Tumors on a Prior Ultrasound Examination
Overview
Affiliations
Background: To evaluate hepatocellular carcinoma (HCC) that developed in patients with no evidence of a tumor during a prior ultrasound (US) performed within 1 year of the diagnosis.
Methods: We retrospectively analyzed data for 100 consecutive patients with liver cirrhosis who had undergone US within 1 year prior to HCC diagnosis and who showed no liver lesions on the previous US. Size and T stage of HCC were assessed as well as whether patients met surgical criteria for liver transplantation as HCC treatment [Milan or University of California at San Francisco (UCSF) criteria].
Results: The mean interval between the negative and diagnostic scans was 5 months, 13 days. HCC presented as a single nodule in 69 patients (size, 0.8-8.0 cm), as two or more nodules in 18 patients, and as the diffuse form of HCC in 13 patients. HCC presented as a small tumor (<3 cm) in 48 patients. T stages were: T1 in 26 patients, T2 in 45, T3 in 18, and T4 in 11. The Milan criteria were met in 79 patients. Eighty-five patients fulfilled the UCSF.
Conclusion: Patients may present with advanced HCC, even if sonographic findings were negative within 1 year prior to diagnosis.
Krishan S, Dhiman R, Kalra N, Sharma R, Baijal S, Arora A J Clin Exp Hepatol. 2019; 9(5):625-651.
PMID: 31695253 PMC: 6823668. DOI: 10.1016/j.jceh.2019.07.005.
An C, Kim D, Choi J, Han K, Roh Y, Kim M BMC Cancer. 2018; 18(1):915.
PMID: 30249190 PMC: 6154402. DOI: 10.1186/s12885-018-4827-2.
Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.
Kagen A, Fowler K, Sirlin C Hepat Oncol. 2018; 1(1):95-105.
PMID: 30190944 PMC: 6114011. DOI: 10.2217/hep.13.11.
Advanced-stage hepatocellular carcinoma presenting without radiographic liver lesions.
Mupamombe C, Veluvolu R, Ahmad A, Preet M, Taiwo E Clin Case Rep. 2018; 6(6):975-982.
PMID: 29881547 PMC: 5985989. DOI: 10.1002/ccr3.1480.
Kim H, Kim K, Choi J, Lee J, Lee C, Kang T BMC Cancer. 2017; 17(1):877.
PMID: 29268722 PMC: 5740703. DOI: 10.1186/s12885-017-3819-y.